(VIANEWS) – SKUE SPAREBANK (SKUE.OL), ORKLA (ORK.OL), AIRBUS (AIR.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SKUE SPAREBANK (SKUE.OL)
11.9% sales growth and 9.5% return on equity
Skue Sparebank provides various banking products and services for individual and business in Norway. The company offers operating, tax deduction, capital, client, deposit, and group accounts; business, construction, personal, vehicle, and small loans, as well as mortgage, bank guarantee, overdraft, and leasing services; and home and leisure, car and other vehicles, pet, company and employees, agriculture insurance products. It also provides savings and pension products; and online and mobile banking, bank card, and payment services. The company was formerly known as Nes Prestegjelds Sparebank and changed its name to Skue Sparebank in October 2013. Skue Sparebank was founded in 1842 and is based in Geilo, Norway.
Earnings Per Share
As for profitability, SKUE SPAREBANK has a trailing twelve months EPS of kr85.05.
PE Ratio
SKUE SPAREBANK has a trailing twelve months price to earnings ratio of 2.59. Meaning, the purchaser of the share is investing kr2.59 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.5%.
More news about SKUE SPAREBANK.
2. ORKLA (ORK.OL)
8.7% sales growth and 13.02% return on equity
Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery channels, as well as food service, convenience stores, and petrol stations. It also provides confectionery, biscuit, and snack products; and develops bran and crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic and wool garments for men, women, and children; and professional cleaning products. Further, it operates Gymgrossisten, Proteinfabrikken, Bodystore, and Fitnessmarket e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, NATURLI', Abba, Beauvais, Den Gamle Fabrik, Spilva, and Vitana brands; confectionery and snacks under the KiMs, Nidar, Stratos, Sætre, Göteborgs Kex, OLW, Panda, Laima, Selga, Taffel, Kalev, and Nói Síríus brands; health and sports nutrition under e Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under the Odense, Mors Hjemmebakte, KronJäst, Bakkedal, and NATURLI brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company was founded in 1918 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, ORKLA has a trailing twelve months EPS of kr5.32.
PE Ratio
ORKLA has a trailing twelve months price to earnings ratio of 15.17. Meaning, the purchaser of the share is investing kr15.17 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.02%.
Yearly Top and Bottom Value
ORKLA’s stock is valued at kr80.72 at 17:20 EST, under its 52-week high of kr83.86 and way higher than its 52-week low of kr67.06.
Volume
Today’s last reported volume for ORKLA is 168583 which is 79.79% below its average volume of 834478.
Sales Growth
ORKLA’s sales growth is 10.4% for the present quarter and 8.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.6%, now sitting on 64.1B for the twelve trailing months.
More news about ORKLA.
3. AIRBUS (AIR.PA)
7% sales growth and 26.56% return on equity
Airbus SE engages in the design, manufacture, and delivery of aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft; freighter aircraft; and regional turboprop aircraft and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment engages in the development, manufacture, marketing, and sale of civil and military helicopters; and provision of helicopter related services. The Airbus Defence and Space segment designs, develops, delivers, and supports military aircraft, such as combat, mission, transport, tanker aircraft, and their associated services; a range of civil and defence space systems for telecommunications, earth observations, navigation, science, and orbital systems; and unmanned aerial systems. This segment also offers missile and space launcher systems, as well as services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. Airbus SE was incorporated in 1998 and is based in Leiden, the Netherlands.
Earnings Per Share
As for profitability, AIRBUS has a trailing twelve months EPS of €4.9.
PE Ratio
AIRBUS has a trailing twelve months price to earnings ratio of 25.38. Meaning, the purchaser of the share is investing €25.38 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.56%.
Yearly Top and Bottom Value
AIRBUS’s stock is valued at €124.38 at 17:20 EST, way under its 52-week high of €138.76 and way higher than its 52-week low of €86.52.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 12.7% and a drop 16.2% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AIRBUS’s EBITDA is 1.6.
More news about AIRBUS.
4. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 5.32% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr0.32.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 72.81. Meaning, the purchaser of the share is investing kr72.81 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.32%.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the current quarter and 6.6% for the next.
Moving Average
VISTIN PHARMA’s worth is above its 50-day moving average of kr22.73 and way higher than its 200-day moving average of kr19.49.
Revenue Growth
Year-on-year quarterly revenue growth grew by 54.7%, now sitting on 410.31M for the twelve trailing months.
Volume
Today’s last reported volume for VISTIN PHARMA is 11961 which is 54.23% below its average volume of 26136.
More news about VISTIN PHARMA.
